Hemab Therapeutics Holdings, Inc.
COAG
6 insider filings · Latest: May 7, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | May 11 9:44 PM | RA CAPITAL MANAGEMENT, L.P.10% Owner | Purchase | 39,869 | $24.81 | $989.2K | 6,365,783(I) | View → |
| May 8, 2026 | May 11 9:44 PM | RA CAPITAL MANAGEMENT, L.P.10% Owner | Purchase | 1,483 | $24.98 | $37.0K | 6,325,914(I) | View → |
| May 7, 2026 | May 11 9:44 PM | RA CAPITAL MANAGEMENT, L.P.10% Owner | Purchase | 9,906 | $24.46 | $242.3K | 6,324,431(I) | View → |
| May 6, 2026 | May 6 11:16 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 68,018 | $24.60 | $1.7M | 6,314,525(I) | View → |
| May 5, 2026 | May 6 11:16 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 97,411 | $24.63 | $2.4M | 6,246,507(I) | View → |
| May 4, 2026 | May 6 11:16 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 2,675,000 | $18.00 | $48.1M | 354,938(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 4, 2026 | May 6 11:16 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Conversion | 219,913 | — | 0(I) | View → |
| May 4, 2026 | May 6 8:55 PM | Novo Holdings A/S10% Owner | Conversion | 190,025 | — | 0(D) | View → |
| May 4, 2026 | May 4 8:20 PM | John MaraganoreDirector | Conversion | 1,634 | — | 0(D) | View → |
| Jan 29, 2026 | May 4 8:20 PM | John MaraganoreDirector | Grant/Award | 107,338 | $6.00 | 107,338(D) | View → |
| Apr 30, 2026 | May 4 8:18 PM | Catherine MadiganChief Medical Officer | Grant/Award | 49,016 | $18.00 | 49,016(D) | View → |
| Jan 29, 2026 | May 4 8:18 PM | Catherine MadiganChief Medical Officer | Grant/Award | 145,134 | $6.00 | 145,134(D) | View → |
| Apr 30, 2026 | May 4 8:16 PM | Mads Nikolaj Behrndt-EriksenChief Financial Officer and General Manager | Grant/Award | 49,016 | $18.00 | 49,016(D) | View → |
| Jan 29, 2026 | May 4 8:16 PM | Mads Nikolaj Behrndt-EriksenChief Financial Officer and General Manager | Grant/Award | 195,206 | $6.00 | 195,206(D) | View → |